An iodine 123-radiolabled small molecule that exhibits high affinity for prostate-specific membrane antigen (PSMA) with potential use in molecular imaging. 123-I-MIP-1095, a radiolabeled glutamate-urea-lysine analogue, selectively binds PSMA, which allows imaging of PSMA-expressing prostate cancer cells with gamma scintigraph. PSMA is a transmembrane glycoprotein highly expressed by malignant prostate epithelial cells and vascular endothelial cells of various solid tumors.
Learn more about 123-I-MIP-1095
- Dailymed label info
- Scientific articles
- Drug portal 123-I-MIP-1095
- toxicity info on 123-I-MIP-1095
- FDA 123-I-MIP-1095